BioLife Solutions Inc.
BLFS
NSC
Sector: Healthcare
Industry: Medical Instruments & Supplies
23.73
USD
1.30
(5.80%)
Optionable: Yes Market Cap: 957 M 90-day average vol: 329,114
Previous close: 22.43 Open: 22.73 Bid: 26.22 Ask: 26.22
52 week range
10.40 58.80
Last updated: Thursday 29th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Financials
BLFS Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 6 M | 9 M | 6 M | 6 M | 8 M | 11 M | 20 M | 27 M | 48 M | 119 M |
| Cost of sales | 3 M | 5 M | 3 M | 2 M | 3 M | 4 M | 6 M | 6 M | 14 M | 65 M |
| Gross operating profit | 2 M | 4 M | 3 M | 4 M | 5 M | 7 M | 14 M | 19 M | 29 M | 42 M |
| Selling Gen & administrative expense | 3 M | 4 M | 5 M | 7 M | 8 M | 7 M | 9 M | 14 M | 21 M | 46 M |
| Research & development expense | 463638 | 487816 | 871100 | 1 M | 2 M | 1 M | 1 M | 3 M | 7 M | 12 M |
| Operating income | -942238 | -285357 | -3 M | -5 M | -5 M | -1 M | 4 M | 770000 | -3 M | -29 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | 94621 | 0 | 4400 | 0 | -3 M | -1 M | -29 M | -4 M | 3 M | 2 M |
| Pre-tax Income (EBT) | -2 M | -1 M | -3 M | -5 M | -8 M | -3 M | -25 M | -3 M | -597000 | -28 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 M | -3 M | -20 M |
| Net income from total operations | -2 M | -1 M | -3 M | -5 M | -8 M | -3 M | -25 M | -2 M | 3 M | -8 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -2 M | -1 M | -3 M | -4 M | -7 M | -3 M | -25 M | -2 M | 3 M | -8 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | 213000 | 339000 | N/A | N/A | N/A |
| Net income available for common | -2 M | -1 M | -3 M | -5 M | -8 M | -3 M | -25 M | -2 M | 3 M | -8 M |
| Depreciation | 169644 | 247072 | 356125 | 433343 | 369894 | 339000 | 338000 | 2 M | 5 M | 13 M |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 M | 3 M | 8 M |
| Operating income before depreciation (EBITDA) | -756512 | -94869 | -3 M | -5 M | -8 M | -2 M | -25 M | 3 M | 2 M | -17 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -0.28 | -0.22 | -0.31 | -0.35 | -0.54 | -0.21 | -1.56 | -0.09 | 0.09 | -0.2 |
| Diluted EPS total | -0.28 | -0.22 | -0.31 | -0.35 | -0.54 | -0.21 | -1.56 | -0.09 | -0.03 | -0.2 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today